ClinicalTrials.gg
RecruitingNCT07133529BuffetUpdated Aug 21, 2025

Decision-making and Food Intake

An interventional study of Perceived food uncertainty and Perceived food certainty in Behavior, Hormones and Stress, sponsored by German Institute of Human Nutrition. Recruiting at 1 site in Germany. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-21.

Sponsored by German Institute of Human Nutrition · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 25 studies in Behavior with a site in Germany — 4 open to participants now, 4 under way, none of them phase 3. Behavior · Germany.

Planned enrollment
17th of 21
45 · median 175
Started
2025
with 1 other
No phase
19 of 25
4 open now
Registered
25th of 25
by date
Lead sponsor
5 of 25
German Institute of Human Nutrition

Among the 25 studies in Behavior with a site in Germany, this one is the 17th largest by planned enrollment of the 21 interventional ones that give a count, is one of 2 that started in 2025, is one of 19 with no phase, and was the 25th registered.

Behavior

1,574 studies on the registry are indexed under Behavior; 312 are open to participants now.

Browse Behavior studies →

Open to participants now

4 of the 25 studies in Behavior with a site in Germany are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 176 Behavior studies recruiting now, 76 (43%) set no upper age limit and 72 (41%) stop at 75 or younger; 57 take children under 18; 99 take healthy volunteers.

This study: 18 Years to 35 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Behavior with a site in Germany, or all of them as a file.
02

Study summary

The study will investigate how the expectation of food availability impacts the response to food cues, mood, interoceptive awareness, and consumption of food intake in healthy, naturally cycling women.

Read the detailed description

In this within-subjects, randomized crossover study, we will probe how perceived meal availability shapes eating behavior, cognition, and metabolic markers in healthy, naturally cycling women. Each woman attends two appointments in the afternoon (starting at 12 pm after an overnight fast): one in which meal timing and duration are fully disclosed ("certain" condition) and one in which that information is intentionally withheld ("uncertain" condition). During each appointment, participants first undergo a set of cognitive and behavioral tests, then are invited to sample ad libitum from a 30-item buffet under the respective certainty or uncertainty instructions. Venous blood is collected at six fixed intervals to measure fluctuations in ghrelin, leptin, insulin, glucose, and cortisol. To capture real-world eating patterns, participants also log all intake in a smartphone food-tracking app for three days leading up to the initial session.

03

Conditions studied

  • Behavior
  • Hormones
  • Stress
  • Cognition
  • Food Intake

Browse trials for

Keywords

  • Decision-making
  • Food intake
  • Food uncertainty
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Nulliparous women (age: 18-35 years) with a regular menstrual cycle (25-32 days)
  • Legally competent/Consent to participate
  • Language proficiency in German (native speaker, fluent)
  • Physically and mentally healthy
  • (BMI) of 18.5 - 30 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Current or use of hormonal in the previous 6 months
  • Current use of hormonal intra-uterine devices (IUDs)
  • Previous or current pregnancy
  • Diagnosed psychological or metabolic disorder
  • Former or current illnesses of:

    1. Brain or mind (including anxiety disorders, depression, eating disorders, personality disorders, alcohol, drugs or drug or non-substance dependence, neurological disorders other than occasional headache, psychiatric or neurological abnomalities)
    2. Heart or blood circulation/cardiovascular disease (myocardial infarction, stroke, hypertension, hypotension, having a pacemaker)
    3. Gastro-intestinal disorders (e.g. colon diseases, irritable bowel syndrome, Crohn's disease)
    4. Endocrine disorders (e.g. thyroid disorders)
    5. Other serious past or present medical conditions (for example, metabolic syndrome, diabetes)
  • Other serious health problems or current severe mental or physical stress.
  • Blood clotting disorder
  • Fear of drawing blood
  • Severe anemia
  • Previously diagnosed hypoglycemia episodes
  • Regular intake of medication (e.g. Antidepressant/anti-anxiety medication)
  • Blood donation within 4 weeks before the study appointment
  • Intake of anticoagulant medications
  • illegal drug consumption
  • smoking or nicotine consumption
  • extreme athletes
  • vegetarians or vegans or any other dietary restrictions due to allergies or intolerances
  • shift workers
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    Perceived food uncertainty

    Behavioral: Perceived food uncertainty

  • Experimental
    Perceived food certainty

    Behavioral: Perceived food certainty

Interventions

  • BehavioralPerceived food uncertainty

    Participants remain unaware of both the scheduled time and the length of the next meal.

  • BehavioralPerceived food certainty

    Participants are aware of both the scheduled time and the length of the next meal.

06

What researchers measure

Primary outcomes

  1. Laboratory food intake

    Food consumed during a laboratory ad libitum buffet task, in which participants are able to order and consume different foods from a menu of their own liking.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  2. Food-specific inhibitory control

    Food-specific inhibitory control measured by a go/no-go task adapted from Teslovich et al., 2014.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  3. Risk propensity on a decision-making task

    In this task, participants decide between a risky/gamble or safe option, based on a paradigm by Liu et al., 2021.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  4. Delay Discounting behavior in a computerized task

    In this task, participants are asked to choose between an immediate and delayed monetary reward, based on a task paradigm by Eisenstein et al., 2015.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  5. Range adaptation in reinforcement learning

    Range adaptation in the context of a reinforcement learning task is assessed using a paradigm described by Gueguen et al., 2024.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  6. Behavioral economic paradigm

    In this task, participants manage a shared resource by deciding how much to extract from a common pool over multiple rounds. Based on their individual extraction, participants receive a monetary reward, which is reduced once the group exceeds a predefined extraction limit. Adapted from Lagenbach et al., 2019.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  7. Heart rate

    Resting-state and task-based heart rate, measured with a three-point electrocardiogram (ECG)

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  8. Heart-rate variability

    Resting-state and task-based heart-rate variability measured with a three-point electrocardiogram (ECG). Respiratory activity will also be recorded using a breathing belt to correct for breathing-related artifacts.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  9. Electrodermal activity

    Resting-state and task-based skin conductance measured with two electrodermal activity electrodes placed on the fingers of the non-dominant hand.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  10. Subjective stress levels

    Subjective stress levels are measured on a semi-continous scale from 1 (not at all) to 100 (extremely) repeatedly during each visit to assess stress responses to perceived food availability. Higher scores indicate greater stress.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  11. Subjective hunger levels

    Subjective hunger levels are measured on a semi-continous scale from 1 (not at all) to 100 (extremely) repeatedly during each visit to assess changes in subjective hunger ratings in response to perceived food availability. Higher scores indicate greater hunger.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  12. Subjective fullness levels

    Subjective fullness levels are measured on a semi-continous scale from 1 (not at all) to 100 (extremely) repeatedly during each visit to assess changes in subjective fullness ratings in response to perceived food availability. Higher scores indicate greater fullness.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  13. Subjective satiety levels

    Subjective satiety levels are measured on a semi-continous scale from 1 (not at all) to 100 (extremely) repeatedly during each visit to assess changes in subjective satiety ratings in response to perceived food availability. Higher scores indicate greater satiation.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  14. Subjective food cravings

    Subjective cravings for sweet, salty, and fatty foods are measured on a semi-continous scale from 1 (not at all) to 100 (extremely) repeatedly during each visit to assess changes in subjective food craving ratings in response to perceived food availability. Higher scores indicate stronger food craving.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  15. Levels of diverse hormones

    Levels of different hormones (e.g., estradiol, progesteron, testosterone, ghrelin, leptin) will be measured via blood sampling.

    Time frame: On 1st and 2nd visit (approximately 30 days later)

  16. Levels of cortisol

    Cortosol levels will be assessed multiple times throughout the visit as an objective measure of stress.

    Time frame: On 1st and 2nd visit (approximately 30 day later)

  17. Insulin levels

    Levels of insulin will be measured multiple times throughout the visit via blood sampling.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  18. Glucose levels

    Glucose levels will be measured multiple times throughout the visit via blood sampling.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  19. Stress eating

    Changes in food intake related to stress is assessed with the Salzburg Stress Eating Scale (SSES; Meule et al., 2018). Higher Scores indicate increased food intake in response to stress, while lower scores indicate reduced food intake when experiencing stress.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  20. Reward-related behavioral activation and inhibition

    Reward-related behavioral activation and inhibition are assessed using the Behavioral Inhibition System/Behavioral Activation System questionnaire (BIS/BAS; Strobel et al., 2001). Participants respond on a four-point Likert scale: "strongly disagree," "disagree," "agree," and "strongly agree." Higher scores on the BIS scale indicate greater behavioral inhibition, while higher scores on the BAS scale reflect stronger behavioral activation.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  21. Impulsivity

    Impulsivity is assessed using the Barratt Impulsiveness Scale (BIS; Meule et al., 2011). Participants respond using a four-point scale: "rarely," "occasionally," "often," and "almost always." Higher scores indicate greater impulsivity.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  22. Mood

    Mood is measured twice during each visit before and after the ad libitum meal using the Positive and Negative Affect Schedule (PANAS; Janke \& Glöckner-Rist, 2014). Participants respond to 20 mood adjectives-10 reflecting positive affect and 10 reflecting negative affect-using a five-point scale: "not at all," "very slightly," "moderately," "quite a bit," and "extremely." Higher scores on the positive affect scale indicate stronger positive mood, while higher scores on the negative affect scale indicate stronger negative mood.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  23. Emotion regulation

    Emotion regulation is assessed using the Emotion Regulation Questionnaire (ERQ; Abler \& Kessler, 2009), which captures individual differences in the use of two distinct strategies to regulate emotions (cognitive reappraisal and expressive suppression). Participants rate their agreement with each item on a seven-point Likert scale, ranging from "strongly disagree" to "strongly agree." Higher scores on each subscale indicate more frequent use of the corresponding regulation strategy.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  24. Perceived stress

    Perceived stress is assessed using the Perceived Stress Scale (PSS-10; Schneider et al., 2020), which aptures the extent to which individuals perceive their lives as unpredictable, uncontrollable, and overwhelming over the past month. Participants respond to general statements using a five-point scale ranging from "never" to "very often." Higher scores indicate greater perceived stress.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  25. State anxiety

    State anxiety is assessed twice during each visit before and after the ad lib meal using the state version of the State-Trait Anxiety Inventory (STAI; Grimm, 2009); which captures the current intensity of anxiety as experienced at the moment of assessment. Response options include "almost never". "a little", "moderately", and "very much". Higher scores indicate higher levels of state anxiety.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  26. Interoceptive awareness

    Interoceptive awareness is assessed using the Multidimensional Assessment of Interoceptive Awareness (MAIA; Eggart et al., 2021). The questionnaire measures various aspects of the awareness of internal bodily sensations. Participants respond to statements using a six-point scale: "never," "very rarely," "rarely," "occasionally," "frequently," and "always." Higher scores reflect greater awareness of bodily sensations.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  27. Loss of control over eating

    Participants will rate their subjective loss of control over eating during the ad lib buffet task. Higher values indicate greater loss of control.

    Time frame: on 1st and 2nd visit (after approximately 30 days)

Secondary outcomes

  1. Habitual food intake

    Self-reported habitual food intake (i.e., all food and drinks consumed) is assessed via an app and/or through additional handwritten food diaries on three consecutive days.

    Time frame: On three days before the 1st visit

  2. Quantification of epigenetic markers related to appetite, menstrual cycle, and stress

    Epigenetic markers associated with appetite regulation, menstrual function, and stress response will be measured in blood samples. Site-specific epigenetic modifications (e.g., DNA methylation or histone modifications) will be quantified using validated molecular assays.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  3. Depressive mood

    Depressive mood is assessed using the German version of the Beck Depression Inventory (BDI; Kühner et al., 2007). The questionnaire measures the severity of depressive symptoms experienced over the past two weeks. Higher total scores indicate more pronounced depressive symptomatology.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  4. Body image

    Body image is assessed using the Body Shape Questionnaire (BSQ; Pook et al., 2008), which measures concerns related to body shape commonly associated with eating disorders. Participants rate how frequently they experience body-related thoughts and feelings. Higher scores indicate greater body shape concern.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  5. Trait food cravings

    Food cravings are measured using the trait version of the Food Cravings Questionnaire (FCQ-T; Meule et al., 2012). Responses are given on a six-point scale from "never/not applicable" to "always," with higher scores indicating more frequent and intense cravings.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  6. Dietary patterns

    Dietary patterns are assessed using a food frequency questionnaire (Haftenberger et al., 2018), which captures the frequency and quantity of consumption across various foods and food groups over the past month. Participants indicate how often they consumed specific items and in which quantity, allowing for an overview of habitual dietary intake and eating patterns.

    Time frame: Day 2 (after approximately 30 days after day 1 i.e., 1st visit)

  7. Intuitive eating

    Intuitive eating is assessed using the Intuitive Eating Scale-2 (van Dyck et al., 2019), which evaluates individuals' tendency to rely on physical hunger and satiety cues to guide decisions about when, what, and how much to eat. Participants respond on a five-point scale ranging from "strongly disagree" to "strongly agree." Higher scores reflect a greater inclination toward intuitive eating behaviors.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  8. Food insecurity status

    Food insecurity status is assessed using the Food Insecurity Experience Scale (FIES; Depa et al., 2018), which evaluates individuals' access to food by addressing factors such as financial constraints, availability, and dietary quality. Response options include "yes," "no," "refused," and "don't know." Higher scores reflect greater severity of food insecurity.

    Time frame: On 1st and 2nd visit (after approximately 30 days)

  9. Restrained eating

    Restrained eating is assessed using the "Cognitive Restraint of Eating" subscale from the Three-Factor Eating Questionnaire (TFEQ; Pudel \& Westenhöfer, 1989). The subscale includes both true/false items and statements rated on a four-point Likert scale ranging from 1 ("always") to 4 ("never"). Higher total scores indicate greater cognitive restraint in eating behavior.

    Time frame: Day 1 (1st visit out of 2)

  10. Eating motives

    Eating motives will be assessed using the Eating Motives Survey (TEMS; Renner et al., 2012). Items are rated on a 7-point Likert scale, ranging from "never" to "always". Higher scores on TEMS subscales indicate a greater reliance on those eating motives when making food or eating choices.

    Time frame: Day 1 (1st visit out of 2)

  11. Family climate

    Family climate is measured using the Familien Klima Skale (FKS; Roth, 2003). Items are rated on a 5-point Likert scale ranging from 1) "does not apply at all," 2) "applies little," 3) "applies moderately," 4) "applies predominantly," to 5) "applies almost completely." Higher total scores indicate a better family climate.

    Time frame: Day 1 (1st visit out of 2)

  12. Attachment styles

    Attachment styles will be assessed using the Adult Attachment Scale (AAS; Schmidt et al., 2004). Items are rated on a five-point Likert scale ranging from "not at all true" to "exactly true." Higher scores on each subscale indicate a stronger endorsement of the corresponding attachment dimension. The subscales/attachment styles assessed are secure, avidant, anxious.

    Time frame: Day 1 (1st visit out of 2)

  13. Gut Microbiome

    To assess the relationship between the gut microbiome and participants' food intake during the ad libitum meal, fecal samples will be collected prior to the first visit, during the observational phase in which participants record their habitual dietary intake.

    Time frame: 1 to three days before the 1st visit

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Haftenberger M, Heuer T, Heidemann C, Kube F, Krems C, Mensink GB. Relative validation of a food frequency questionnaire for national health and nutrition monitoring. Nutr J. 2010 Sep 14;9:36. doi: 10.1186/1475-2891-9-36. PubMed 20840739 ↗
  • Langenbach BP, Baumgartner T, Cazzoli D, Muri RM, Knoch D. Inhibition of the right dlPFC by theta burst stimulation does not alter sustainable decision-making. Sci Rep. 2019 Sep 25;9(1):13852. doi: 10.1038/s41598-019-50322-w. PubMed 31554883 ↗
  • Teslovich T, Freidl EK, Kostro K, Weigel J, Davidow JY, Riddle MC, Helion C, Dreyfuss M, Rosenbaum M, Walsh BT, Casey BJ, Mayer L. Probing behavioral responses to food: development of a food-specific go/no-go task. Psychiatry Res. 2014 Sep 30;219(1):166-70. doi: 10.1016/j.psychres.2014.04.053. Epub 2014 May 10. PubMed 24909971 ↗
  • Schmidt S, Strauss B, Hoger D, Brahler E. [The Adult Attachment Scale (AAS) - psychometric evaluation and normation of the German version]. Psychother Psychosom Med Psychol. 2004 Sep-Oct;54(9-10):375-82. doi: 10.1055/s-2003-815000. German. PubMed 15343479 ↗
  • Renner B, Sproesser G, Strohbach S, Schupp HT. Why we eat what we eat. The Eating Motivation Survey (TEMS). Appetite. 2012 Aug;59(1):117-28. doi: 10.1016/j.appet.2012.04.004. Epub 2012 Apr 19. PubMed 22521515 ↗
  • Depa J, Gyngell F, Muller A, Eleraky L, Hilzendegen C, Stroebele-Benschop N. Prevalence of food insecurity among food bank users in Germany and its association with population characteristics. Prev Med Rep. 2018 Jan 28;9:96-101. doi: 10.1016/j.pmedr.2018.01.005. eCollection 2018 Mar. PubMed 29527460 ↗
  • Meule A, Lutz A, Vogele C, Kubler A. Food cravings discriminate differentially between successful and unsuccessful dieters and non-dieters. Validation of the Food Cravings Questionnaires in German. Appetite. 2012 Feb;58(1):88-97. doi: 10.1016/j.appet.2011.09.010. Epub 2011 Sep 29. PubMed 21983051 ↗
  • Pook M, Tuschen-Caffier B, Brahler E. Evaluation and comparison of different versions of the Body Shape Questionnaire. Psychiatry Res. 2008 Feb 28;158(1):67-73. doi: 10.1016/j.psychres.2006.08.002. Epub 2007 Nov 26. PubMed 18037499 ↗
  • Kuhner C, Burger C, Keller F, Hautzinger M. [Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples]. Nervenarzt. 2007 Jun;78(6):651-6. doi: 10.1007/s00115-006-2098-7. German. PubMed 16832698 ↗
  • Eggart M, Todd J, Valdes-Stauber J. Validation of the Multidimensional Assessment of Interoceptive Awareness (MAIA-2) questionnaire in hospitalized patients with major depressive disorder. PLoS One. 2021 Jun 25;16(6):e0253913. doi: 10.1371/journal.pone.0253913. eCollection 2021. PubMed 34170963 ↗
  • Schneider EE, Schonfelder S, Domke-Wolf M, Wessa M. Measuring stress in clinical and nonclinical subjects using a German adaptation of the Perceived Stress Scale. Int J Clin Health Psychol. 2020 May-Aug;20(2):173-181. doi: 10.1016/j.ijchp.2020.03.004. Epub 2020 May 22. PubMed 32550857 ↗
  • Meule A, Reichenberger J, Blechert J. Development and preliminary validation of the Salzburg Stress Eating Scale. Appetite. 2018 Jan 1;120:442-448. doi: 10.1016/j.appet.2017.10.003. Epub 2017 Oct 3. PubMed 28986162 ↗
  • Gueguen MCM, Anllo H, Bonagura D, Kong J, Hafezi S, Palminteri S, Konova AB. Recent Opioid Use Impedes Range Adaptation in Reinforcement Learning in Human Addiction. Biol Psychiatry. 2024 May 15;95(10):974-984. doi: 10.1016/j.biopsych.2023.12.005. Epub 2023 Dec 13. PubMed 38101503 ↗
  • Liu L, Artigas SO, Ulrich A, Tardu J, Mohr PNC, Wilms B, Koletzko B, Schmid SM, Park SQ. Eating to dare - Nutrition impacts human risky decision and related brain function. Neuroimage. 2021 Jun;233:117951. doi: 10.1016/j.neuroimage.2021.117951. Epub 2021 Mar 12. PubMed 33722669 ↗
  • Eisenstein SA, Gredysa DM, Antenor-Dorsey JA, Green L, Arbelaez AM, Koller JM, Black KJ, Perlmutter JS, Moerlein SM, Hershey T. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity. PLoS One. 2015 Jul 20;10(7):e0133621. doi: 10.1371/journal.pone.0133621. eCollection 2015. PubMed 26192187 ↗

Related links

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Jul 2026, 11 months after the start.

Of 740 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 11 months is below that.

Counting every sponsor, half of 756 studies reached it within 13 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2025
First posted
Aug 21, 2025
StartActual
Aug 4, 2025
Primary completionEst.
Jul 31, 2026
CompletionEst.
Jul 31, 2026
Last update
Aug 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07133529
Lead sponsor
German Institute of Human Nutrition
Responsible party
Prof. Dr. Soyoung Q Park (Prof. Dr., German Institute of Human Nutrition) — Principal investigator
First posted
Aug 21, 2025
Start date
Aug 4, 2025
Primary completion
Jul 31, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Aug 21, 2025

Study contacts

Renée Sophie Cuntz, MSc
Contact
Renee.Cuntz@dife.de
+49 33 200 88 2519
Elisa Rehbein, Dr.
Contact
elisa.rehbein@dife.de
+49 33 200 88 - 2525
Soyoung Q Park, Prof. Dr.
principal investigator · German Institute of Human Nutrition Potsdam-Rehbruecke

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion